MBX   $28.43  -0.94% Market Closed After Close 28.78 1.23%

MBX Biosciences, Inc.
Total Cash 55.26M
totalCashPerShare 3.49
EBITDA -50.72M
Total Debt 249.00K
quickRatio 6.761
currentRatio 7.173
Total Revenue
debtToEquity 0.457
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -42.85M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 452.99M
forwardPE -9.681034
floatShares 6.55M
sharesOutstanding 33.38M
sharesShort 363.74K
sharesShortPriorMonth 0.00
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.77%
Short Ratio help_outline 2.03%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -6.182
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -47.20M
trailingEps -1.48%
forwardEps -2.32%
enterpriseToEbitda -8.93
lastDividendValue
lastDividendDate
currentQuarterEstimate -2.72
institutionsCount 10
lastUpdated Nov. 2, 2024, 8:07 a.m.